2010
DOI: 10.1016/j.fertnstert.2010.07.310
|View full text |Cite
|
Sign up to set email alerts
|

Effects of advanced maternal age are abrogated in 122 patients undergoing transfer of embryos with euploid microarray screening results at cleavage stage

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
3
0

Year Published

2010
2010
2013
2013

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 0 publications
1
3
0
Order By: Relevance
“…This study shows vastly improved outcomes even when including cycles with no euploid embryos to transfer. The reduction in miscarriages suggested in this study is consistent with other retrospective studies that have shown a decrease in miscarriage rates in patients with recurrent pregnancy loss treated with CCS [14,22,27]. This study does have several limitations.…”
Section: Discussionsupporting
confidence: 88%
“…This study shows vastly improved outcomes even when including cycles with no euploid embryos to transfer. The reduction in miscarriages suggested in this study is consistent with other retrospective studies that have shown a decrease in miscarriage rates in patients with recurrent pregnancy loss treated with CCS [14,22,27]. This study does have several limitations.…”
Section: Discussionsupporting
confidence: 88%
“…This is particularly true in light of the experiences with FISH-based aneuploidy screening which was suggested to be clinically beneficial based on case–control studies ( Gianaroli et al ., 1997 ; Munne et al ., 1999 ; Kahraman et al ., 2000 ; Munne et al ., 2003 ; Munne et al ., 2006 ), despite failing to show a meaningful benefit in all randomized controlled clinical trials (reviewed in Fritz, 2008 ). Although similar case–control and observational clinical studies using comprehensive methods of aneuploidy screening have been reported ( Wells et al ., 2009 ; Munne et al ., 2010 ; Rabinowitz et al ., 2010 ; Schoolcraft et al ., 2010a ,b), randomized controlled trials have been limited. Indeed, class I strength of evidence for a significant improvement in clinical pregnancy and embryo implantation rates (i.e.…”
Section: Introductionmentioning
confidence: 99%
“…Although largely clinically un-validated, comparative data with other platforms suggest better efficiency than both FISH and aCGH for aneuploidy screening (Johnson et al 2010b;Treff et al 2010a;Treff et al 2010b). Recently presented clinical data of SNP array based PGS on cleavage stage embryos suggests significant improvement of pregnancy rates following embryo transfer (Rabinowitz et al 2010).We anticipate that with further clinical validation, SNP genotyping will become the gold standard for PGS in the near future.…”
Section: Single Nucleotide Polymorphism (Snp) Arraysmentioning
confidence: 98%